"What is the exact nature of the promotions you think AMRN can now make in light of 1A decision. Are they not the same as those supported by the literature zumantu has placed on this board?"
As far as the current situation regarding Amarin's ability to use the medical literature, I agree with you R-I will have no effect on it..I am against retaining the status quo...because I believe there is a good chance the FDA will give us the ANCHOR label expansion before the RI results are known..And that is an important difference..
News 
Market Data 
Discover 
